Compounded monoclonal antibodies

A Tender Notice
by BERKSHIRE HEALTHCARE NHS FOUNDATION TRUST

Source
Find a Tender
Type
Contract (Goods)
Duration
23.5 month
Value
£54M-£54M
Sector
HEALTH
Published
17 Feb 2021
Delivery
To 09 Mar 2023 (est.)
Deadline
19 Mar 2021 10:00

Concepts

Location

United Kingdom:

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Provision of Compounded monoclonal antibodies to Thames Valley and Wessex Trusts as follows: Berkshire Healthcare NHS Foundation Trust Buckinghamshire Healthcare NHS Trust Dorset County Hospital NHS Foundation Trust Dorset HealthCare University NHS Foundation Trust Frimley Health NHS Foundation Trust Hampshire Hospitals NHS Foundation Trust Isle of Wight NHS Trust Milton Keynes University Hospital NHS Foundation Trust Oxford Health NHS Foundation Trust Oxford University Hospitals NHS Foundation Trust Portsmouth Hospitals NHS Trust Royal Berkshire NHS Foundation Trust Solent NHS Trust Southern Health NHS Foundation Trust University Hospitals Dorset NHS Foundation Trust University Hospital Southampton NHS Foundation Trust The requirement will be split into 17 Lots as follows: 1 COMPOUNDED ATEZOLIZUMAB 2 COMPOUNDED BEVACIZUMAB 3 COMPOUNDED CETUXIMAB 4 COMPOUNDED DARATUMUMAB 5 COMPOUNDED NIVOLUMAB 6 COMPOUNDED OBINUTUZUMAB 7 COMPOUNDED PANITUMUMAB 8 COMPOUNDED PEMBROLIZUMAB 9 COMPOUNDED PERTUZUMAB 10 COMPOUNDED RITUXIMAB (MABTHERA) 11 COMPOUNDED RITUXIMAB (RIXATHON) 12 COMPOUNDED RITUXIMAB (TRUXIMA) 13 COMPOUNDED TRASTUZUMAB (HERCEPTIN) 14 COMPOUNDED TRASTUZUMAB (HERZUMA) 15 COMPOUNDED TRASTUZUMAB (ONTRUZANT) 16 COMPOUNDED TRASTUZUMAB (KANJINTI) 17 COMPOUNDED TRASTUZUMAB (TRAZIMERA) This will be a ranked framework with a maximum of 5 suppliers per lot.

Lot Division

1 COMPOUNDED ATEZOLIZUMAB
  • Value: £2M

COMPOUNDED ATEZOLIZUMAB
2 COMPOUNDED BEVACIZUMAB
  • Value: £868K

COMPOUNDED BEVACIZUMAB
3 COMPOUNDED CETUXIMAB
  • Value: £1M

COMPOUNDED CETUXIMAB
4 COMPOUNDED DARATUMUMAB
  • Value: £2M

COMPOUNDED DARATUMUMAB
5 COMPOUNDED NIVOLUMAB
  • Value: £1M

COMPOUNDED NIVOLUMAB
6 OCOMPOUNDED BINUTUZUMAB
  • Value: £522K

COMPOUNDED OBINUTUZUMAB
7 COMPOUNDED PANITUMUMAB
  • Value: £156K

COMPOUNDED PANITUMUMAB
8 COMPOUNDED PEMBROLIZUMAB
  • Value: £19M

COMPOUNDED PEMBROLIZUMAB
9 COMPOUNDED PERTUZUMAB
  • Value: £11M

COMPOUNDED PERTUZUMAB
10 COMPOUNDED RITUXIMAB (MABTHERA)
  • Value: £139K

COMPOUNDED RITUXIMAB (MABTHERA)
11 COMPOUNDED RITUXIMAB (RIXATHON)
  • Value: £4M

COMPOUNDED RITUXIMAB (RIXATHON)
12 COMPOUNDED RITUXIMAB (TRUXIMA)
  • Value: £4M

COMPOUNDED RITUXIMAB (TRUXIMA)
13 COMPOUNDED TRASTUZUMAB (HERCEPTIN)
  • Value: £1M

COMPOUNDED TRASTUZUMAB (HERCEPTIN)
14 COMPOUNDED TRASTUZUMAB (HERZUMA)
  • Value: £1M

COMPOUNDED TRASTUZUMAB (HERZUMA)
15 COMPOUNDED TRASTUZUMAB (ONTRUZANT)
  • Value: £5M

COMPOUNDED TRASTUZUMAB (ONTRUZANT)
16 COMPOUNDED TRASTUZUMAB (KANJINTI)
  • Value: £4K

COMPOUNDED TRASTUZUMAB (KANJINTI)
17 COMPOUNDED TRASTUZUMAB (TRAZIMERA)
  • Value: £4K

COMPOUNDED TRASTUZUMAB (TRAZIMERA)

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Variant bids are not accepted.
  • This is a one-off contract (no recurrence)
  • Renewals are not available.
  • Professional qualifications are sought.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains